Did the COVID-19 Pandemic Just Turn TAVR Into an Outpatient Procedure?

Giri, Jay; Fiorilli, Paul N

Giri, Jay; Fiorilli, Paul N.

Giri J; Department of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: jay.giri@pennmedicine.upenn.edu.
Fiorilli PN; Department of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

JACC Cardiovasc Interv ; 15(6): 599-602, 2022 03 28.

Article in English | MEDLINE | ID: covidwho-1926614

Subject(s)

COVID-19; Transcatheter Aortic Valve Replacement; Humans; Outpatients; Pandemics/prevention & control; Transcatheter Aortic Valve Replacement/adverse effects; Transcatheter Aortic Valve Replacement/methods; Treatment Outcome

Keywords

aortic stenosis; healthcare delivery; transcatheter aortic valve replacement

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Transcatheter Aortic Valve Replacement / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: JACC Cardiovasc Interv Journal subject: Vascular Diseases / Cardiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google